EE288 Decision Model to Evaluate the Cost of Clinical Events Associated with Switching from Apixaban to Rivaroxaban Among Patients with Non-Valvular Atrial Fibrillation in Germany
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.587
https://www.valueinhealthjournal.com/article/S1098-3015(24)00702-2/fulltext
Title :
EE288 Decision Model to Evaluate the Cost of Clinical Events Associated with Switching from Apixaban to Rivaroxaban Among Patients with Non-Valvular Atrial Fibrillation in Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00702-2&doi=10.1016/j.jval.2024.03.587
First page :
Section Title :
Open access? :
No
Section Order :
10064